Ryan Michael P, Hinojosa Jennifer J
The University of Texas at San Antonio, USA.
Health Psychol Open. 2015 Dec 23;2(2):2055102915624928. doi: 10.1177/2055102915624928. eCollection 2015 Jul.
Some smokers have safety and cost concerns about nicotine replacement therapy which discourage its use. We recruited 56 young adult light smokers to read detailed descriptions of a hybrid nicotine replacement therapy, a prescription drug treatment, scheduled reduced smoking, and a menu of self-help tactics. Participants listed five reasons smokers might reject each strategy. An emergent-category content analysis classified each response with a high degree of inter-rater reliability. Only one-third of 32 concerns were strategy-specific; the majority focused on the general difficulty of quitting. Most prevalent were "continued cravings," "addiction too strong," "takes too long," and "won't work." These and other concerns reflect conceptual obstacles to be surmounted in smoking-cessation interventions.
一些吸烟者对尼古丁替代疗法存在安全和成本方面的担忧，这阻碍了该疗法的使用。我们招募了56名年轻的轻度吸烟者，让他们阅读关于一种混合尼古丁替代疗法、一种处方药治疗、计划减少吸烟量以及一系列自助策略的详细描述。参与者列出了吸烟者可能拒绝每种策略的五个原因。一项新出现类别内容分析以高度的评分者间信度对每个回答进行了分类。32个担忧中只有三分之一是针对特定策略的；大多数集中在戒烟的总体困难上。最普遍的是“持续渴望”“成瘾性太强”“耗时太长”和“不起作用”。这些及其他担忧反映了戒烟干预中需要克服的概念障碍。
